Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2003
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003US20030219662 Electrophotographic organophotoreceptors with novel charge transport compounds
11/27/2003CA2497601A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003CA2486339A1 Substituted ring-fused imidazole derivates: gabaa receptor ligands
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2485012A1 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364951A1 Pest controllers
11/26/2003EP1364950A1 Pyridopyrimidine or naphthyridine derivative
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363909A2 Tricyclic androgen receptor modulator compounds
11/26/2003EP1363908A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
11/26/2003EP1363907A2 Heterocycle carboxamides as antiviral agents
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363630A2 Kappa opioid receptor ligands
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1214319B1 Imidazo-pyridine derivatives as ligands for gaba receptors
11/26/2003EP0757038B1 Benzamide compound and medicinal use thereof
11/26/2003EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1128797C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C- linked imidazoles
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/25/2003US6653654 Light emitting diodes having electrodes, charge tranfer compounds, emitter layers comprising mixtures of beryllium bis(2-(2'-hydroxyphenyl)pyridine) and platinum complexes as dopes; brightness; heat resistance
11/25/2003US6653477 Imidazopyridin-8-ones
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653320 Such as 3-(6-bromo-2-methylimidazo(1,2-a)pyridin-3-yl)-1H-pyrazol-1-yl 2-methyl-5-nitrophenyl sulfone; useful as phosphatidylinositol-3-kinase (PI3K) inhibitors and antitumor agents
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653303 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11/25/2003US6653302 Quinoline and quinazoline compounds useful in therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653295 Protease inhibitor; viricide
11/25/2003CA2061168C The preparation and use of 3, (4)-substituted pyrrolidines as catalysts for the polyisocyanate polyaddition process
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095453A1 Compounds against helicobacter activity
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003095448A1 Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003094917A1 Vintoperol-containing medicinal composition for transdermal administration
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003032984A8 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
11/20/2003WO2003029210A3 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216568 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
11/20/2003US20030216450 Inhibitors of dipeptidyl peptidase IV
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216424 Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216415 Kinase inhibitor; angiogenesis inhibitor; anticancer agents; leukemia
11/20/2003US20030216402 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216390 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
11/20/2003US20030216389 Therapeutic morpholino-substituted compounds
11/20/2003US20030216379 Substituted fused pyrazolecarboxylic acid arylamides and related compounds
11/20/2003US20030216374 Antibiotic oxazolidinone derivatives
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/19/2003EP1362081A1 Acid pigment dispersants and pigment preparations
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1361868A1 Novel modified release formulation
11/19/2003EP1117401B1 Antibiotic compositions for treatment of the eye
11/19/2003EP0898571B1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
11/19/2003EP0796849B1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1457337A Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
11/19/2003CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines
11/19/2003CN1456556A Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines
11/19/2003CN1456154A Method for curing sepsis
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649762 Crystal modification C of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihyro-4-oxo-3-quinoline carboxylic
11/18/2003US6649638 Prenylation inhibitors and methods of their synthesis and use
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649625 Agent for prophylaxis and treatment of glaucoma
11/18/2003US6649624 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649089 Red fluorescent material as dopes
11/13/2003WO2003093283A1 Electroluminescent materials
1 ... 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 ... 646